HEADER OXIDOREDUCTASE 08-JAN-08 2VL3 TITLE OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXIREDOXIN-5; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 2-162; COMPND 5 SYNONYM: PRX-V, PEROXISOMAL ANTIOXIDANT ENZYME, PLP, THIOREDOXIN COMPND 6 REDUCTASE, THIOREDOXIN PEROXIDASE PMP20, ANTIOXIDANT ENZYME B166, COMPND 7 AOEB166, TPX TYPE VI, LIVER TISSUE 2D-PAGE SPOT 71B, ALU COREPRESSOR COMPND 8 1, HUMAN PEROXIREDOXIN 5; COMPND 9 EC: 1.11.1.15; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LUNG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI M15; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1007065; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE-30 KEYWDS THIOREDOXIN PEROXIDASE, ALTERNATIVE INITIATION, ANTIOXIDANT ENZYME, KEYWDS 2 REDOX-ACTIVE CENTER, CYTOPLASM, PEROXIDASE, PEROXISOME, ANTIOXIDANT, KEYWDS 3 POLYMORPHISM, MITOCHONDRION, PEROXIREDOXIN, OXIDOREDUCTASE, TRANSIT KEYWDS 4 PEPTIDE, THIOREDOXIN FOLD EXPDTA X-RAY DIFFRACTION AUTHOR A.SMEETS,J.P.DECLERCQ REVDAT 6 13-DEC-23 2VL3 1 REMARK REVDAT 5 24-JUL-19 2VL3 1 REMARK REVDAT 4 10-JUL-19 2VL3 1 REMARK REVDAT 3 24-OCT-18 2VL3 1 SOURCE REMARK REVDAT 2 24-FEB-09 2VL3 1 VERSN REVDAT 1 26-AUG-08 2VL3 0 JRNL AUTH A.SMEETS,C.MARCHAND,D.LINARD,B.KNOOPS,J.P.DECLERCQ JRNL TITL THE CRYSTAL STRUCTURES OF OXIDIZED FORMS OF HUMAN JRNL TITL 2 PEROXIREDOXIN 5 WITH AN INTRAMOLECULAR DISULFIDE BOND JRNL TITL 3 CONFIRM THE PROPOSED ENZYMATIC MECHANISM FOR ATYPICAL 2-CYS JRNL TITL 4 PEROXIREDOXINS. JRNL REF ARCH.BIOCHEM.BIOPHYS. V. 477 98 2008 JRNL REFN ISSN 0003-9861 JRNL PMID 18489898 JRNL DOI 10.1016/J.ABB.2008.04.036 REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 51613 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2633 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 49.91 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.05420 REMARK 3 B22 (A**2) : -0.00070 REMARK 3 B33 (A**2) : 0.05490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3640 REMARK 3 ANGLE : 1.208 4925 REMARK 3 CHIRALITY : 0.082 571 REMARK 3 PLANARITY : 0.006 646 REMARK 3 DIHEDRAL : 17.458 1331 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1290034908. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-SEP-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8156 REMARK 200 MONOCHROMATOR : SI 111, HORIZONTALLY FOCUSSING REMARK 200 OPTICS : MIRROR 2 BENT, VERTICALLY REMARK 200 FOCUSSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51613 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 19.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.370 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1HD2 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NACL 0.1 M TRIS PH 8 0.1 M PEG 3350 REMARK 280 20% REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.24500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.24500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.17500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.06000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.17500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.06000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.24500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.17500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 51.06000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 73.24500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.17500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 51.06000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.24500 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2043 LIES ON A SPECIAL POSITION. REMARK 375 HOH C2043 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A -10 REMARK 465 GLY A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 ARG B -10 REMARK 465 GLY B -9 REMARK 465 SER B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 ARG C -10 REMARK 465 GLY C -9 REMARK 465 SER C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 50 -58.27 -128.19 REMARK 500 ASP A 99 76.79 -115.43 REMARK 500 ASP A 113 -157.04 -83.35 REMARK 500 THR A 150 -94.51 -141.44 REMARK 500 THR B 50 -62.91 -138.44 REMARK 500 LYS B 93 -50.93 -131.60 REMARK 500 ASP B 113 -155.01 -76.56 REMARK 500 ASP B 134 30.68 37.67 REMARK 500 THR B 150 -99.12 -138.92 REMARK 500 SER B 159 -9.83 -55.06 REMARK 500 CYS C 47 74.61 46.64 REMARK 500 ASP C 113 -159.02 -73.25 REMARK 500 THR C 147 -18.28 63.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2003 DISTANCE = 6.16 ANGSTROMS REMARK 525 HOH A2027 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH B2034 DISTANCE = 5.94 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OC3 RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 1H4O RELATED DB: PDB REMARK 900 MONOCLINIC FORM OF HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 1HD2 RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 1URM RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5, C47S MUTANT REMARK 900 RELATED ID: 2VL2 RELATED DB: PDB REMARK 900 OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 DBREF 2VL3 A -10 0 PDB 2VL3 2VL3 -10 0 DBREF 2VL3 A 1 161 UNP P30044 PRDX5_HUMAN 2 162 DBREF 2VL3 B -10 0 PDB 2VL3 2VL3 -10 0 DBREF 2VL3 B 1 161 UNP P30044 PRDX5_HUMAN 2 162 DBREF 2VL3 C -10 0 PDB 2VL3 2VL3 -10 0 DBREF 2VL3 C 1 161 UNP P30044 PRDX5_HUMAN 2 162 SEQRES 1 A 172 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA PRO SEQRES 2 A 172 ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL PHE SEQRES 3 A 172 GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU LEU SEQRES 4 A 172 PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO GLY SEQRES 5 A 172 ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO GLY SEQRES 6 A 172 PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY VAL SEQRES 7 A 172 GLN VAL VAL ALA CYS LEU SER VAL ASN ASP ALA PHE VAL SEQRES 8 A 172 THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY LYS SEQRES 9 A 172 VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY LYS SEQRES 10 A 172 GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER ILE SEQRES 11 A 172 PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL VAL SEQRES 12 A 172 GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO ASP SEQRES 13 A 172 GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE ILE SEQRES 14 A 172 SER GLN LEU SEQRES 1 B 172 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA PRO SEQRES 2 B 172 ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL PHE SEQRES 3 B 172 GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU LEU SEQRES 4 B 172 PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO GLY SEQRES 5 B 172 ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO GLY SEQRES 6 B 172 PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY VAL SEQRES 7 B 172 GLN VAL VAL ALA CYS LEU SER VAL ASN ASP ALA PHE VAL SEQRES 8 B 172 THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY LYS SEQRES 9 B 172 VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY LYS SEQRES 10 B 172 GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER ILE SEQRES 11 B 172 PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL VAL SEQRES 12 B 172 GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO ASP SEQRES 13 B 172 GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE ILE SEQRES 14 B 172 SER GLN LEU SEQRES 1 C 172 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA PRO SEQRES 2 C 172 ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL PHE SEQRES 3 C 172 GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU LEU SEQRES 4 C 172 PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO GLY SEQRES 5 C 172 ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO GLY SEQRES 6 C 172 PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY VAL SEQRES 7 C 172 GLN VAL VAL ALA CYS LEU SER VAL ASN ASP ALA PHE VAL SEQRES 8 C 172 THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY LYS SEQRES 9 C 172 VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY LYS SEQRES 10 C 172 GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER ILE SEQRES 11 C 172 PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL VAL SEQRES 12 C 172 GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO ASP SEQRES 13 C 172 GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE ILE SEQRES 14 C 172 SER GLN LEU FORMUL 4 HOH *396(H2 O) HELIX 1 1 LEU A 25 LYS A 30 1 6 HELIX 2 2 THR A 44 THR A 50 1 7 HELIX 3 3 THR A 50 GLN A 58 1 9 HELIX 4 4 GLN A 58 ALA A 64 1 7 HELIX 5 5 ASP A 77 HIS A 88 1 12 HELIX 6 6 GLY A 102 ASP A 109 1 8 HELIX 7 7 ASP A 113 SER A 115 5 3 HELIX 8 8 LEU A 116 GLY A 121 1 6 HELIX 9 9 LEU A 153 SER A 159 1 7 HELIX 10 10 LEU B 25 LYS B 30 1 6 HELIX 11 11 THR B 44 THR B 50 1 7 HELIX 12 12 THR B 50 GLN B 58 1 9 HELIX 13 13 GLN B 58 LYS B 65 1 8 HELIX 14 14 ASP B 77 HIS B 88 1 12 HELIX 15 15 GLY B 102 ASP B 109 1 8 HELIX 16 16 LEU B 116 GLY B 121 1 6 HELIX 17 17 LEU B 153 SER B 159 1 7 HELIX 18 18 LEU C 25 LYS C 30 1 6 HELIX 19 19 CYS C 47 THR C 50 5 4 HELIX 20 20 HIS C 51 GLN C 58 1 8 HELIX 21 21 GLN C 58 LYS C 65 1 8 HELIX 22 22 ASP C 77 HIS C 88 1 12 HELIX 23 23 GLY C 102 ASP C 109 1 8 HELIX 24 24 LEU C 116 GLY C 121 1 6 HELIX 25 25 GLY C 146 THR C 150 5 5 HELIX 26 26 ASN C 156 LEU C 161 5 6 SHEET 1 AA 2 GLU A 13 PHE A 15 0 SHEET 2 AA 2 LYS A 22 ASN A 24 -1 O VAL A 23 N VAL A 14 SHEET 1 AB 5 ARG A 95 ALA A 98 0 SHEET 2 AB 5 VAL A 67 SER A 74 1 O VAL A 70 N ARG A 95 SHEET 3 AB 5 LYS A 33 GLY A 38 1 O LYS A 33 N GLN A 68 SHEET 4 AB 5 PHE A 128 GLN A 133 -1 O PHE A 128 N GLY A 38 SHEET 5 AB 5 ILE A 136 VAL A 142 -1 O ILE A 136 N GLN A 133 SHEET 1 BA 2 GLU B 13 PHE B 15 0 SHEET 2 BA 2 LYS B 22 ASN B 24 -1 O VAL B 23 N VAL B 14 SHEET 1 BB 5 ARG B 95 ALA B 98 0 SHEET 2 BB 5 VAL B 69 SER B 74 1 O VAL B 70 N ARG B 95 SHEET 3 BB 5 LYS B 33 GLY B 38 1 O VAL B 35 N ALA B 71 SHEET 4 BB 5 PHE B 128 GLN B 133 -1 O PHE B 128 N GLY B 38 SHEET 5 BB 5 ILE B 136 VAL B 142 -1 O ILE B 136 N GLN B 133 SHEET 1 CA 2 GLU C 13 PHE C 15 0 SHEET 2 CA 2 LYS C 22 ASN C 24 -1 O VAL C 23 N VAL C 14 SHEET 1 CB 5 ARG C 95 ALA C 98 0 SHEET 2 CB 5 VAL C 69 SER C 74 1 O VAL C 70 N ARG C 95 SHEET 3 CB 5 LYS C 33 GLY C 38 1 O VAL C 35 N ALA C 71 SHEET 4 CB 5 PHE C 128 GLN C 133 -1 O PHE C 128 N GLY C 38 SHEET 5 CB 5 ILE C 136 VAL C 142 -1 O ILE C 136 N GLN C 133 SSBOND 1 CYS C 47 CYS C 151 1555 1555 2.05 CRYST1 78.350 102.120 146.490 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012763 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009792 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006826 0.00000